{"organizations": [], "uuid": "6700156332245bb4262970ae41a8c3683607aa6a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-pfizer-reports-q1-earnings-of-059/brief-pfizer-reports-q1-earnings-of-0-59-per-share-idUSASC09YI4", "country": "US", "domain_rank": 408, "title": "BRIEF-Pfizer Reports Q1 Earnings Of $0.59 Per Share", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-01T14:14:00.000+03:00", "replies_count": 0, "uuid": "6700156332245bb4262970ae41a8c3683607aa6a"}, "author": "", "url": "https://www.reuters.com/article/brief-pfizer-reports-q1-earnings-of-059/brief-pfizer-reports-q1-earnings-of-0-59-per-share-idUSASC09YI4", "ord_in_thread": 0, "title": "BRIEF-Pfizer Reports Q1 Earnings Of $0.59 Per Share", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters st", "sentiment": "negative"}, {"name": "pfizer", "sentiment": "none"}, {"name": "pfizer inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 1, 2018 / 11:16 AM / in 6 minutes BRIEF-Pfizer Reports Q1 Earnings Of $0.59 Per Share Reuters Staff\nMay 1 (Reuters) - Pfizer Inc:\n* PFIZER REPORTS FIRST-QUARTER 2018 RESULTS * Q1 EARNINGS PER SHARE $0.59\n* Q1 EARNINGS PER SHARE VIEW $0.74 — THOMSON REUTERS I/B/E/S * REAFFIRMED ALL COMPONENTS OF 2018 FINANCIAL GUIDANCE\n* QTRLY INNOVATIVE HEALTH SEGMENT REVENUE $7,829 MILLION VERSUS $7,415 MILLION * Q1 REVENUE VIEW $13.13 BILLION — THOMSON REUTERS I/B/E/S\n* 2018 FINANCIAL GUIDANCE FOR ADJUSTED DILUTED EPS NOW ANTICIPATES SHARE REPURCHASES TOTALING ABOUT $6.1 BILLION IN 2018\n* PFIZER - CONTINUES TO EXPECT THAT ANY DECISION REGARDING STRATEGIC ALTERNATIVES FOR CONSUMER HEALTHCARE WILL BE MADE DURING 2018\n* PFIZER - Q1 ESSENTIAL HEALTH BUSINESS NEGATIVELY IMPACTED BY CONTINUED LEGACY HOSPIRA PRODUCT SUPPLY SHORTAGES IN U.S., PRODUCT LOSSES OF EXCLUSIVITY\n* PFIZER-2018 GUIDANCE REFLECTS ANTICIPATED NEGATIVE REVENUE IMPACT OF $2.0 BILLION DUE TO RECENT, EXPECTED GENERIC, BIOSIMILAR COMPETITION FOR CERTAIN PRODUCTS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)", "external_links": [], "published": "2018-05-01T14:14:00.000+03:00", "crawled": "2018-05-01T14:29:26.009+03:00", "highlightTitle": ""}